nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—Risedronate—osteoporosis	0.664	0.668	CbGbCtD
Lornoxicam—CYP2C9—Estropipate—osteoporosis	0.171	0.172	CbGbCtD
Lornoxicam—CYP2C9—Cholecalciferol—osteoporosis	0.0881	0.0886	CbGbCtD
Lornoxicam—CYP2C9—Estradiol—osteoporosis	0.071	0.0714	CbGbCtD
Lornoxicam—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—osteoporosis	0.000346	0.0621	CbGpPWpGaD
Lornoxicam—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000322	0.0577	CbGpPWpGaD
Lornoxicam—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000256	0.0458	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000196	0.0352	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	0.000182	0.0326	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000156	0.0279	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000131	0.0235	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	0.000118	0.0211	CbGpPWpGaD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	9.28e-05	0.0166	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	8.5e-05	0.0152	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	8.39e-05	0.015	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	8.18e-05	0.0147	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	8e-05	0.0143	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	7.43e-05	0.0133	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP27A1—osteoporosis	6.96e-05	0.0125	CbGpPWpGaD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	6.93e-05	0.0124	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	6.9e-05	0.0124	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	6.89e-05	0.0123	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.89e-05	0.0123	CbGpPWpGaD
Lornoxicam—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	6.35e-05	0.0114	CbGpPWpGaD
Lornoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	6.15e-05	0.011	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	5.57e-05	0.00998	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	5.57e-05	0.00997	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	5.48e-05	0.00981	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	5.34e-05	0.00956	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	5.09e-05	0.00912	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	4.7e-05	0.00842	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.66e-05	0.00834	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4.47e-05	0.008	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	4.42e-05	0.00792	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.41e-05	0.00791	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	4.41e-05	0.00789	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	4.24e-05	0.00759	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	4.21e-05	0.00754	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.14e-05	0.00741	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	4.13e-05	0.0074	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	4.04e-05	0.00724	CbGpPWpGaD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	3.76e-05	0.00674	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	3.73e-05	0.00668	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.7e-05	0.00662	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	3.66e-05	0.00656	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP19A1—osteoporosis	3.66e-05	0.00655	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.62e-05	0.00648	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	3.61e-05	0.00647	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.5e-05	0.00628	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.43e-05	0.00615	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.34e-05	0.00599	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.94e-05	0.00527	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.9e-05	0.00519	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	2.79e-05	0.005	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—LEP—osteoporosis	2.75e-05	0.00492	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.72e-05	0.00488	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.7e-05	0.00483	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.68e-05	0.00481	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.67e-05	0.00479	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.66e-05	0.00476	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	2.52e-05	0.00452	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.45e-05	0.00438	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.32e-05	0.00416	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.27e-05	0.00407	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	2.21e-05	0.00397	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—POMC—osteoporosis	2.2e-05	0.00394	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.18e-05	0.0039	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.12e-05	0.0038	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PKM—osteoporosis	2.07e-05	0.00371	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—FDPS—osteoporosis	2.07e-05	0.00371	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	2.02e-05	0.00362	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PGLS—osteoporosis	1.97e-05	0.00352	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GPD2—osteoporosis	1.97e-05	0.00352	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SOST—osteoporosis	1.97e-05	0.00352	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PKM—osteoporosis	1.97e-05	0.00352	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	1.92e-05	0.00344	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	1.9e-05	0.0034	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PGLS—osteoporosis	1.86e-05	0.00334	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ANTXR2—osteoporosis	1.86e-05	0.00334	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.8e-05	0.00323	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.8e-05	0.00323	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ATIC—osteoporosis	1.8e-05	0.00322	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PNP—osteoporosis	1.8e-05	0.00322	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	1.79e-05	0.00321	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.78e-05	0.00319	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.76e-05	0.00315	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	1.75e-05	0.00314	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PKM—osteoporosis	1.65e-05	0.00295	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—FDPS—osteoporosis	1.65e-05	0.00295	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	1.63e-05	0.00293	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	1.61e-05	0.00288	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GSN—osteoporosis	1.58e-05	0.00284	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PGLS—osteoporosis	1.56e-05	0.0028	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GPD2—osteoporosis	1.56e-05	0.0028	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.54e-05	0.00277	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—OXCT1—osteoporosis	1.53e-05	0.00274	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CA2—osteoporosis	1.53e-05	0.00274	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MGLL—osteoporosis	1.49e-05	0.00267	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PNP—osteoporosis	1.43e-05	0.00256	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ATIC—osteoporosis	1.43e-05	0.00256	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.41e-05	0.00252	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.4e-05	0.00252	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—LRP5—osteoporosis	1.38e-05	0.00247	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MYC—osteoporosis	1.36e-05	0.00244	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	1.36e-05	0.00244	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—LRP6—osteoporosis	1.32e-05	0.00236	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	1.3e-05	0.00232	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TNF—osteoporosis	1.27e-05	0.00228	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—IDH2—osteoporosis	1.27e-05	0.00227	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RPL24—osteoporosis	1.27e-05	0.00227	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—LTF—osteoporosis	1.27e-05	0.00227	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CA2—osteoporosis	1.21e-05	0.00217	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—OXCT1—osteoporosis	1.21e-05	0.00217	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.2e-05	0.00214	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP27A1—osteoporosis	1.19e-05	0.00213	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MGLL—osteoporosis	1.18e-05	0.00212	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ACP5—osteoporosis	1.16e-05	0.00208	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—POMC—osteoporosis	1.16e-05	0.00207	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.14e-05	0.00205	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.12e-05	0.002	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ACP5—osteoporosis	1.1e-05	0.00197	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—FDPS—osteoporosis	1.09e-05	0.00195	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PKM—osteoporosis	1.09e-05	0.00195	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TPI1—osteoporosis	1.08e-05	0.00193	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PGLS—osteoporosis	1.03e-05	0.00185	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPD2—osteoporosis	1.03e-05	0.00185	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL6—osteoporosis	1.03e-05	0.00184	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TPI1—osteoporosis	1.02e-05	0.00183	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—P4HB—osteoporosis	1.01e-05	0.00181	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—IDH2—osteoporosis	1.01e-05	0.0018	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GAPDH—osteoporosis	9.94e-06	0.00178	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—RAP1A—osteoporosis	9.68e-06	0.00173	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—P4HB—osteoporosis	9.6e-06	0.00172	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP27A1—osteoporosis	9.45e-06	0.00169	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PNP—osteoporosis	9.45e-06	0.00169	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ATIC—osteoporosis	9.45e-06	0.00169	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GAPDH—osteoporosis	9.42e-06	0.00169	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.28e-06	0.00166	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.25e-06	0.00166	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACP5—osteoporosis	9.2e-06	0.00165	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.08e-06	0.00163	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NFATC1—osteoporosis	8.95e-06	0.0016	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—DKK1—osteoporosis	8.88e-06	0.00159	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.64e-06	0.00155	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—WNT1—osteoporosis	8.55e-06	0.00153	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TPI1—osteoporosis	8.55e-06	0.00153	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.44e-06	0.00151	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGA—osteoporosis	8.32e-06	0.00149	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—P4HB—osteoporosis	8.04e-06	0.00144	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—OXCT1—osteoporosis	8.04e-06	0.00144	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CA2—osteoporosis	8.04e-06	0.00144	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GAPDH—osteoporosis	7.89e-06	0.00141	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MGLL—osteoporosis	7.83e-06	0.0014	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ENO1—osteoporosis	7.82e-06	0.0014	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PSMA2—osteoporosis	7.71e-06	0.00138	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PSMA5—osteoporosis	7.71e-06	0.00138	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—RAP1A—osteoporosis	7.68e-06	0.00138	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ENO1—osteoporosis	7.42e-06	0.00133	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.38e-06	0.00132	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PSMA2—osteoporosis	7.31e-06	0.00131	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PSMA5—osteoporosis	7.31e-06	0.00131	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CALCA—osteoporosis	6.81e-06	0.00122	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.7e-06	0.0012	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—IDH2—osteoporosis	6.66e-06	0.00119	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP27A1—osteoporosis	6.26e-06	0.00112	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP19A1—osteoporosis	6.26e-06	0.00112	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ENO1—osteoporosis	6.21e-06	0.00111	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KL—osteoporosis	6.18e-06	0.00111	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PSMA2—osteoporosis	6.12e-06	0.0011	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PSMA5—osteoporosis	6.12e-06	0.0011	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACP5—osteoporosis	6.09e-06	0.00109	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.01e-06	0.00108	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TPI1—osteoporosis	5.66e-06	0.00101	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—P4HB—osteoporosis	5.32e-06	0.000954	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GAPDH—osteoporosis	5.22e-06	0.000936	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ADCY5—osteoporosis	5.11e-06	0.000916	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GPX1—osteoporosis	5.09e-06	0.000912	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—RAP1A—osteoporosis	5.09e-06	0.000912	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP19A1—osteoporosis	4.97e-06	0.00089	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ADCY5—osteoporosis	4.84e-06	0.000868	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—osteoporosis	4.7e-06	0.000842	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—osteoporosis	4.46e-06	0.000798	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.44e-06	0.000795	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IRS2—osteoporosis	4.24e-06	0.000759	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ENO1—osteoporosis	4.11e-06	0.000737	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADCY5—osteoporosis	4.06e-06	0.000727	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PSMA2—osteoporosis	4.05e-06	0.000726	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PSMA5—osteoporosis	4.05e-06	0.000726	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GPX1—osteoporosis	4.04e-06	0.000724	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—POMC—osteoporosis	3.76e-06	0.000673	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—osteoporosis	3.73e-06	0.000668	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IRS1—osteoporosis	3.7e-06	0.000663	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6R—osteoporosis	3.48e-06	0.000623	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP19A1—osteoporosis	3.29e-06	0.000589	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—POMC—osteoporosis	2.98e-06	0.000535	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADCY5—osteoporosis	2.69e-06	0.000481	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPX1—osteoporosis	2.68e-06	0.00048	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—osteoporosis	2.47e-06	0.000443	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MYC—osteoporosis	2.06e-06	0.000369	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFB1—osteoporosis	2.05e-06	0.000368	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—POMC—osteoporosis	1.98e-06	0.000354	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—osteoporosis	1.55e-06	0.000277	CbGpPWpGaD
